First, WNT5a induces IL12 [6], which is central to psoriasis, as indicated by the therapeutic efficacy of antibodies targeted at IL12p40 and by the genetic association of IL12 with psoriasis [24], [25]. The gene discussed is WNT5A; the disease is psoriasis.